Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland.
Support Care Cancer
; 30(5): 3655-3659, 2022 May.
Article
in En
| MEDLINE
| ID: mdl-34993650
ABSTRACT
Not monitoring adherence to oral anticancer therapies (OAT) can lead to poor clinical outcomes, including premature death as reported by Foulon et al. (Acta Clin Belg 66(2)85-96, 2011) and Greer et al. (Oncologist 21(3)354-76, 2016). Barriers to the implementation of supportive cancer care interventions in medication adherence occur with multiple hospital sites, cancer diagnoses, and numerous healthcare professionals. This commentary describes challenges and strategies from two OAT adherence trials in Australia and Switzerland to assist researchers in the design and implementation of future interprofessional trials.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Medication Adherence
/
Neoplasms
Limits:
Humans
Country/Region as subject:
Europa
/
Oceania
Language:
En
Journal:
Support Care Cancer
Journal subject:
NEOPLASIAS
/
SERVICOS DE SAUDE
Year:
2022
Type:
Article
Affiliation country:
Switzerland